XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
2. SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Service Fee Revenue

 

The Company’s total net revenues during the three and six months ended June 30, 2018 and 2017 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
Commercial insurance   $ 145,538     $ 142,691     $ 281,981     $ 283,683  
Medicare     50,302       47,611       95,867       95,291  
Medicaid     6,928       6,525       13,179       13,259  
Workers' compensation/personal injury     8,660       8,867       17,407       17,925  
Other (1)     7,988       8,362       15,150       16,648  
Service fee revenue, net of contractual allowances and discounts     219,416       214,056       423,584       426,806  
Provision for bad debts           (11,854 )           (23,500 )
Net service fee revenue     219,416       202,202       423,584       403,306  
Revenue under capitation arrangements     24,979       27,812       52,203       55,721  
Total net revenue   $ 244,395     $ 230,014     $ 475,787     $ 459,027  

___________________

  (1) Other consists of revenue from teleradiology services, consulting fees and software revenue.
Schedule of goodwill and other intangible assets

Activity in goodwill for the six months ended June 30, 2018 is provided below (in thousands):

 

Balance as of December 31, 2017   $ 256,776  
 Goodwill acquired through the acquisition of Imaging Services Company of New York, LLC     2,692  
 Goodwill acquired through the acquisition of certain assets of MemorialCare Medical Foundation     10,158  
 Goodwill transferred to assets held for sale     (1,059 )
 Goodwill acquired through the acquisition of Women's Imaging Specialists in Healthcare     4,089  
 Goodwill acquired through the acquisition of Valley Metabolic Imaging     1,469  
 Goodwill acquired through the acquisition of Sierra Imaging Associates     1,147  
Balance as of June 30, 2018   $ 275,272  

Effect of derivative instruments on comprehensive income

A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss is as follows (amounts in thousands):

 

For the three months ended June 30, 2018
                       
Account     April 1, 2018 Balance       Amount of gain recognized on derivative       June 30, 2018 Balance     Location
Other Comprehensive Income     2,725       1,199       3,924     Current Assets & Equity

 

For the six months ended June 30, 2018
                             
Account     Jan 1, 2018 Balance       Amount of gain recognized on derivative       June 30, 2018 Balance     Location
Other Comprehensive Income     (370 )     4,294       3,924     Current Assets & Equity
Schedule of fair value of assets and liabilities

The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our consolidated balance sheets, as follows (in thousands):

 

    As of June 30, 2018  
    Level 1     Level 2     Level 3     Total  
Current and other non-current liabilities                                
Interest Rate Contracts   $     $ 5,159     $     $ 5,159  

 

      As of December 31, 2017  
      Level 1       Level 2       Level 3       Total   
Current assets                                
Interest Rate Contracts   $     $ (595 )   $     $ (595 )
Schedule of fair value and carrying amount of our long-term debt

The table below summarizes the estimated fair value and carrying amount of our long-term debt as follows (in thousands):

 

    As of June 30, 2018  
    Level 1     Level 2     Level 3     Total Fair Value     Total Face Value  
First Lien Term Loans   $     $ 605,240     $     $ 605,240     $ 603,731  
                                         

 

    As of December 31, 2017  
    Level 1     Level 2     Level 3     Total     Total Face Value  
First Lien Term Loans   $     $ 628,801     $     $ 628,801     $ 620,272  
Earnings per share

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
Net income (loss) attributable to RadNet, Inc.'s common stockholders   $ 5,406     $ 5,310     $ (1,932 )   $ 4,100  
                                 
BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS                                
Weighted average number of common shares outstanding during the period     47,969,003       46,756,276       47,896,216       46,662,420  
Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders   $ 0.11     $ 0.11     $ (0.04 )   $ 0.09  
                                 
DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS                                
Weighted average number of common shares outstanding during the period     47,969,003       46,756,276       47,896,216       46,662,420  
Add nonvested restricted stock subject only to service vesting     409,162       250,153             198,477  
Add additional shares issuable upon exercise of stock options and warrants     147,868       189,469             207,666  
Weighted average number of common shares used in calculating diluted net income per share     48,526,033       47,195,898       47,896,216       47,068,563  
Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders   $ 0.11     $ 0.11     $ (0.04 )   $ 0.09  
                                 
Stock options excluded from the computation of diluted per share amounts:                                
Weighted average shares for which the exercise price exceeds average market price of common stock           165,000             325,575  
Investment in joint ventures

The following table is a summary of our investment in joint ventures during the six months ended June 30, 2018 (in thousands):

 

Balance as of December 31, 2017   $ 52,435  
Equity in earnings in these joint ventures     6,725  
Distribution of earnings     (7,083 )
 Equity contributions in existing and purchase of interest in joint ventures     2,000  
Balance as of June 30, 2018   $ 54,077  
Joint venture investment and financial information

The following table is a summary of key balance sheet data for these joint ventures as of June 30, 2018 and December 31, 2017 and income statement data for the six months ended June 2018 and 2017 (in thousands):

 

Balance Sheet Data:   June 30, 2018     December 31, 2017  
Current assets   $ 42,880     $ 47,813  
Noncurrent assets     106,758       107,481  
Current liabilities     (14,324 )     (16,655 )
Noncurrent liabilities     (37,745 )     (42,072 )
Total net assets   $ 97,569     $ 96,567  
                 
Book value of RadNet joint venture interests   $ 45,964     $ 45,935  
Cost in excess of book value of acquired joint venture interests     8,113       6,500  
Total value of Radnet joint venture interests   $ 54,077     $ 52,435  
                 
Total book value of other joint venture partner interests   $ 51,605     $ 50,632  
                 
Income statement data for the six months ended June 30,     2018       2017  
Net revenue   $ 91,559     $ 86,981  
Net income   $ 14,174     $ 10,285